Biotech companies, 6 month 17 day focus on technology transfers and global cooperation discussions at BIO USA
Onhill 17 day began developing an Alzheimer's drug validation platform (Phase 0.5). Domestic biotech companies including Algonomics and OliX held discussions on technology cooperation, including RNA editing, and technology transfers at BIO USA in the United States on the same day. Koscom signed a contract with GTN to build a global order hub, while Daewon Media successfully concluded KCCF.
Domestic biotech companies 6 month 17 day focused on discussing technology transfers and global cooperation at BIO USA in the United States. The outcomes of the discussions held there could lead to technology transfer agreements and clinical and development partnerships, drawing strong investor interest.
Onhill 17 day announced that it had begun developing an Alzheimer's drug validation platform called 'Phase 0.5'. The company explained that it would use the platform to validate the initial efficacy and safety of drug candidates.
Algonomics announced that it had discussed the possibility of global cooperation centered on its RNA editing platform on the same day. The company said it had discussed technology co-development and application plans with overseas partners.
Dong-A Socio Group participated in BIO USA, seeking overseas partnerships and business opportunities. OliX said it held discussions on site regarding technology transfers and joint development.
KOSCOM disclosed that it had signed a contract with GTN to build a global order hub. The two companies announced that they would jointly establish order-processing and overseas connectivity infrastructure.
Daewon Media reported that it had successfully concluded the global culture fair KCCF. It said that overseas buyers and content companies participated in the fair.